U.S. Hospitality Stock News

Wondering if BlackRock at around US$1,062 per share is still a sensible entry point, or if much of the value is already reflected in the price? This article focuses squarely on what the current valuation is telling you. Over the very short term, the stock has returned 1.3% over 7 days and 9.0% over 30 days. Returns sit at 21.5% over 1 year, 75.2% over 3 years and 46.7% over 5 years, with a slightly negative return of 2.1% year to date. Recent headlines around BlackRock have highlighted its...

F.N.B. Corporation (NYSE:FNB) has entered an exclusive banking partnership with Penn State, covering all university campuses. The agreement makes F.N.B. the primary banking partner for the Penn State community, expanding its presence across the university system. F.N.B. has also appointed a new Chief Commercial Banking Officer to focus on corporate and institutional client relationships. For investors watching regional financial institutions, F.N.B. Corporation sits at the intersection of...

Bank of America recently initiated coverage of The New York Times Company with a Neutral rating, recognizing its subscription-focused, multi-product digital platform but flagging valuation and AI-related traffic risks. This follows the company’s participation at the NAB Show 2026, where its Director of Newsroom Audience highlighted how audience engagement is evolving across formats. We’ll now examine how Bank of America’s Neutral initiation, especially its AI traffic concerns, interacts...

If you are wondering whether Carvana's share price still makes sense after its recent run, this breakdown will help you put the current level into context. The stock last closed at US$416.79, with returns of 12.3% over 7 days, 39.1% over 30 days, 4.1% year to date and 88.6% over the past year. That naturally raises questions about what is already priced in. Recent headlines have focused on Carvana's position in online used car retailing and how investors are reacting to its progress on key...

A federal jury in North Carolina found Uber legally responsible for a driver's assault on a passenger, classifying the company as a common carrier under state law. The verdict, part of broader multi district litigation, imposes a heightened duty of care for rider safety on Uber and comes with minimal damages awarded to the plaintiff. This case marks the second such jury outcome this year involving rideshare safety and adds to thousands of similar claims pending nationwide. For investors...

Aurora Innovation (AUR) is drawing fresh attention after subsidiary Aurora Operations applied to US regulators for a five year exemption covering warning equipment on Level 4 autonomous commercial trucks. See our latest analysis for Aurora Innovation. The regulatory filing arrives after a strong run, with a 30 day share price return of 18.04% and a year to date share price return of 33.59%. This performance comes even though the 1 year total shareholder return shows a 19.84% decline, which...

Why Alcoa (AA) Is Back on Investors’ Radar Alcoa (AA) has drawn fresh attention after recent share price moves, with the stock showing a 2.1% gain over the past day and a 22.2% return over the past month. See our latest analysis for Alcoa. That 22.2% 1-month share price return and 21.2% year-to-date share price return, alongside a very large 1-year total shareholder return of 176.6%, point to strong positive momentum after a softer recent week. If you are looking beyond Alcoa for other...

Why Airbnb is back in focus ahead of earnings Airbnb (ABNB) is drawing fresh attention as it starts listing independent hotels in major cities while investors also look ahead to the upcoming quarterly earnings report and expectations for profit growth. See our latest analysis for Airbnb. At a share price of US$144.18, Airbnb has logged a 1-day share price return of 1.07% and a 30-day share price return of 8.74%. The 1-year total shareholder return of 21.90% points to momentum building into...

MGIC Investment Corporation previously declared a quarterly cash dividend of US$0.15 per share for the period ended March 31, 2026, payable on May 21, 2026, to shareholders of record as of May 6, 2026. Alongside this dividend, MGIC’s recent strong quarterly results, ongoing buybacks, and an expanded multiyear reinsurance program underscore its focus on capital strength and risk transfer. Now, we’ll explore how MGIC’s stronger quarterly performance and expanded reinsurance agreement may...

Event context and recent share performance DT Midstream (DTM) has recently drawn attention after a period of mixed share performance, with a small gain over the past day, a modest decline over the past week, and a larger pullback over the past month. Over the past 3 months, the stock shows a positive total return. Over the past year and the past 3 years, total returns are higher again, which may prompt investors to reassess the current pricing of the business. See our latest analysis for DT...

Wondering whether Stoke Therapeutics at around US$35.90 is offering solid value or stretching expectations? This article breaks down what the current price might actually be implying about the business. The stock has posted returns of 1.0% over the last week, 7.5% over the last month, 16.2% year to date and 277.1% over the past year, which puts recent price action firmly on investors' radar. Recent coverage around Stoke Therapeutics has focused on its role in the biotech space and ongoing...

Kennametal overview and recent share performance Kennametal (KMT) has attracted attention after a strong run in its shares, with the stock recently closing at US$38.98 and posting positive returns over the past month, the past 3 months, and year to date. See our latest analysis for Kennametal. Beyond the recent move to US$38.98, Kennametal’s 30 day share price return of 9.40% and year to date share price return of 34.46% sit alongside a 1 year total shareholder return of 110.97%. Together,...

If you are wondering whether DXC Technology at around US$12.82 is a bargain or a value trap, the starting point is understanding what the current market price is implying about its future. The stock has returned 1.5% over the last 7 days and 5.7% over the last 30 days. Yet year to date it is down 8.9% and over 1 year the return is a 15.4% decline, with 3 and 5 year returns of 43.9% and 59.8% decline respectively. Recent headlines around DXC have focused on its position in the IT services...

Investors may be wondering whether Comfort Systems USA at around US$1,724.49 is still offering value, or if most of the easy gains are already behind it. The stock has posted returns of 4.6% over 7 days, 22.5% over 30 days, 71.8% year to date and very large multi-year gains, including about 12x over 3 years and more than 20x over 5 years. Recent coverage has focused on Comfort Systems USA as a construction and building services provider that has attracted attention following its strong...

Tripadvisor (NasdaqGS:TRIP) has entered a cooperation agreement with activist investor Starboard Value. The deal gives Starboard immediate and upcoming representation on Tripadvisor’s board of directors. The board plans to review options for a potential sale of the company and for Tripadvisor’s restaurant booking unit, TheFork. For you as an investor, this puts fresh attention on Tripadvisor’s core role as a travel reviews and booking platform and on TheFork as a separate, restaurant...

What Jabil’s Recent Share Move Tells You Jabil (JBL) has attracted attention after a strong recent share move, with the stock showing double digit returns over the past month and past 3 months. For investors, the question is how that performance lines up with the company’s current fundamentals. See our latest analysis for Jabil. Beyond the recent surge, Jabil’s 30 day share price return of 26.34% and 90 day share price return of 37.47% sit alongside a very large 5 year total shareholder...

Why Viking Therapeutics (VKTX) Is Back on Watchlists Viking Therapeutics (VKTX) has drawn renewed attention after recent share price moves. The stock closed at US$34.25 and has shown mixed performance over the past week, month, and past 3 months. See our latest analysis for Viking Therapeutics. The recent 1 day share price return of 1.33% and 30 day share price return of 5.22% sit against a year to date share price decline of 3.30%, while the 1 year total shareholder return of 32.80% and 5...

The U.S. fiscal 2027 budget proposal points to a sharp rise in Space Force spending on satellite communications and missile defense, putting Intuitive Machines (LUNR) and its Lanteris subsidiary squarely in focus for potential defense contracts. See our latest analysis for Intuitive Machines. Intuitive Machines has seen strong momentum recently, with a 1-day share price return of 7.62%, a 30-day share price return of 47.42%, and a 1-year total shareholder return of 280.92%, as investors react...

Kinsale Capital Group (KNSL) has drawn investor attention after recent share price swings, including a 2.6% move lower over the past day, set against mixed returns over the month and the past 3 months. See our latest analysis for Kinsale Capital Group. Looking beyond the recent 1 day share price decline, Kinsale Capital Group’s 30 day share price return of 6.54% contrasts with a 90 day share price return of 14.22% and a 1 year total shareholder return decline of 28.78%. This suggests momentum...

Wondering if StoneCo at US$15.08 is offering value or simply treading water? This breakdown will help you size up the stock before you commit new capital. The share price shows mixed signals, with a 1.1% return over the last 7 days, 7.3% over 30 days, 2.7% year to date, 15.7% over 1 year, 28.7% over 3 years, but a 78.3% decline over 5 years. Recent coverage around StoneCo has focused on how the stock's long term pullback and more recent positive returns have shifted sentiment among investors...

If you are wondering whether TriMas is still attractively priced after a strong run, this breakdown will help you see how the current share price lines up with several valuation checks. The stock closed at US$36.18, with returns of 2.5% over 30 days, a 0.3% decline year to date, and 73.2% over the last year, which has put the question of value and risk front and center for many investors. Recent coverage around TriMas has focused on its position in the packaging and materials space and how...

If you are wondering whether Colgate-Palmolive at around US$82 per share offers fair value or a potential mispricing, the key is to look past the brand name and into what the current market price actually reflects. The stock has eased back recently, with a 1.4% decline over the last 7 days and a 3.3% decline over the last 30 days, even though the year to date return sits at 6.0% and the 1 year return is 10.1% lower. These moves sit against a broader backdrop of ongoing interest in defensive...

Hayward Holdings stock snapshot after recent performance swings Hayward Holdings (HAYW) has seen mixed share performance recently, with a 1 day pullback, a gain over the past week and month, and a decline across the past 3 months and year to date. See our latest analysis for Hayward Holdings. While the latest share price of US$15.16 sits below recent highs, the 30 day share price return of 9.46% contrasts with a 90 day decline of 9.38% and a 1 year total shareholder return of 21.28%. This...

If you are wondering whether Quest Diagnostics at around US$204 is offering solid value or asking too much, you are in the right place for a closer look at what that price actually reflects. The stock has recorded returns of 6.6% over the last 7 days, 4.3% over 30 days, 17.4% year to date, 19.7% over 1 year, 47.5% over 3 years and 70.8% over 5 years. Recent price action is therefore an important part of the valuation story. Recent news coverage has focused on Quest Diagnostics as a key...